Liposomal Nanocarriers to Enhance Skin Delivery of Chemotherapeutics in Cancer Therapy
Cancer chemotherapeutics administered to cancer patients via traditional oral or parenteral routes often encounter poor bioavailability and severe systemic side effects. Skin delivery is a promising alternative route with reduced side effects and improved therapeutic efficacy and has gained signific...
Gorde:
| Egile Nagusiak: | , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
MDPI AG
2025-01-01
|
| Saila: | Bioengineering |
| Gaiak: | |
| Sarrera elektronikoa: | https://www.mdpi.com/2306-5354/12/2/133 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|